Report on how AI is redefining market landscape - The Global Gastrointestinal Diseases Therapeutics Market size is es ...

The U.S. FDA Breakthrough Therapy designation is for the treatment of adults with non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH) and moderate or advanced fibrosis, based on surv ...

Market: Industry Trends and Global Forecasts to 2035: Distribution by Type of Molecule, Active Compound Used, Type of GLP-1 ...

Diabetic retinopathy appears to be more common in young people than earlier thought, leaving more of them at risk for eye ...

The CEO of pharmaceuticals giant Roche has urged authorities to block the takeover of contract drug manufacturer Catalent by ...

Insulin Biosimilar MarketThe global insulin biosimilar market is on track for significant expansion, with an estimated valuation of approximately USD 3,008.0 million in 2024. Exhibiting a year-on-year ...

The financial regulator has sent warning letters to 10 manufacturers disputing more than 300 patent listings in its Orange Book covering 20 brands used for diabetes, weight loss, asthma ...

European countries and a handful of non-profit groups have committed $700 million (€627.4 million) to fund the World Health ...

The "Biopharmaceuticals Contract Manufacturing - Market Insights, Competitive Landscape, Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.The biopharmaceuticals contract ...

The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce ...